Mr Akhilesh

COUNTRY COMPARISON PHARMAJANUARY 2011

Revision History
Date | Revision Number | Document Manager | Revision Purpose |
| | | |
| | | |
| | | |

-------------------------------------------------


Table of Contents
1 THE HEALTH CARE SECTOR 5
1.1.1 Country Structure India 5
1.1.2 Population- India 5
1.1.3 Pharmaceutical Spend per Capita- India 6
1.1.4 Disease Profile - India 6
1.1.5 Healthcare Sector - India 6
1.1.6 Healthcare Funding - India 7
1.1.7 Healthcare Insurance - India 9
1.2.1 The Health Sector Malaysia 10
1.2.2 Malaysia Key Economic Indicators 11
1.2.3 Malaysia Healthcare Sector 12
1.2.4 Malaysia Healthcare Structure 13
1.2.5 Malaysia Healthcare Sector Funding 14
1.2.6 Malaysia Healthcare Initiatives 15
1.2.7 Malaysia Medical Tourism 15
2 INDUSTRY OVERVIEW 18
2.1.1 Pharmaceutical SWOT Analysis- India 18
2.1.2 Indian Economic SWOT- India 20
2.1.3 India Political SWOT- India 23
2.2 Malaysia Industry Overview 25
2.2.1 Malaysia Country Strengths Pharmaceuticals and Healthcare Industry SWOT 25
2.2.2 Malaysia Political SWOT 28
2.2.3 Malaysia Political SWOT Malaysia Economic SWOT 30
2.2.4 Malaysia Business Environment SWOT 31
2.2.5 Malaysia Industry Structure 32
2.2.6 Malaysia Industry Size 33
2.2.7 Malaysia Priority Status for Pharma 33
2.2.8 Malaysia Industry Structure 34
2.2.9 Malaysia Industry Size 35
2.2.10 Malaysia Priority Status for Pharma 36
2.2.11 Malaysia Overview- Pharmaceutical Industry 36
3 PHARMACEUTICAL REGULATORY REGIME 39
3.1.1 IP Laws - India 39
3.1.2 Approval times- India 39
3.1.3 Recent Regulatory Developments - India 40
3.1.4 Biotechnology Regulatory Board - India 40
3.1.5 US FDA’s new office- India 41
3.1.6 IP Regime - India 41
3.1.7 Pricing and Reimbursement- India 41
3.2 Malaysia Regulatory Regime 43
3.2.1 Malaysia Incentives 43
3.2.2 Malaysia Regulation 44
3.3.3 Malaysia Regulation 45
4 PHARMACEUTICAL PRODUCTION- MANUFACTURING 47
5 PHARMACEUTICAL MARKET 48
5.1.1...